Statera Biopharma, Inc., a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced that the Company filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 with the Securities and Exchange Commission.
October 21, 2022
· 6 min read